Accelerate Diagnostics Investor Relations Material
Latest events
Q3 2024
Accelerate Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Accelerate Diagnostics Inc
Access all reports
Accelerate Diagnostics Inc. is an in vitro diagnostics company specializing in rapid diagnostic solutions for infectious diseases. The company develops and markets systems and tests that enable the identification of pathogens and the determination of antimicrobial susceptibility directly from patient samples. Its flagship product, the Accelerate Pheno system, provides faster diagnostic results compared to traditional methods, helping healthcare providers optimize antimicrobial therapy and improve patient outcomes. The company is headquartered in Tucson, Arizona, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
AXDX
Country
🇺🇸 United States